Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × Chemotherapy, Adjuvant × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 7 Rectal Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 4 Stomach Neoplasms 2 Neoplasm, Residual 2 Nasopharyngeal Carcinoma 2 Mesothelioma, Malignant 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Triple Negative Breast Neoplasms 1 Solitary Fibrous Tumor, Pleural 1 Sarcopenia 1 Sarcoglycanopathies 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Neoplasm Metastasis 1 NSCLC 1 Microsatellite Instability 1 Mesothelioma 1 Melanoma 1 Malnutrition 1 Lung Neoplasms 1 HER2 Negative Breast Cancer 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Frailty 1 Esophageal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 4 Specimen Handling 3 Doxorubicin 3 Radiotherapy 2 Radiation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Biopsy 2 tremelimumab 1 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 olaratumab 1 futibatinib 1 fludarabine 1 eribulin 1 durvalumab 1 cabozantinib 1 avelumab 1 aldesleukin 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Histamine H2 Antagonists 1 Famotidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡